Inventor · disambiguated record
Linglong Kong
Also filed as: KONG LINGLONG
1 granted patent·10 pending applications·6 citations·filing 2017–2022
26Inventor score
Files withHANGZHOU GLUBIO PHARMACEUTICAL CO LTD3JANSSEN PHARMACEUTICA NV3JANSSEN SCIENCES IRELAND UNLIMITED CO3ABBVIE INC1Replica Analytics1
Top patents by PatentIndex Score
11 records- 0183US11396517B1Exo-aza spiro inhibitors of menin-MLL interactionJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Jul 26, 2022·6 cites·13 claims
- 0257US2023039917A1Exo-aza spiro inhibitors of menin-mll interactionJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 0354US2025049798A1Wee1 protein kinase degradation agent and use thereofHANGZHOU GLUBIO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0454US2024360150A1Isoindolinone compounds and uses thereofHANGZHOU GLUBIO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0550US2023002408A1Heteroaryldihydropyrimidine derivatives and methods of treating hepatitis b infectionsJANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
- 0648US2022267313A1Dihydropyrimidine derivatives and uses thereof in the treatment of hbv infection or of hbv-induced diseasesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2020·Application pending·0 cites
- 0746US2022281865A1Dihydropyrimidine derivatives and uses thereof in the treatment of hbv infection or of hbv-induced diseasesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2020·Application pending·0 cites
- 0846US2024294500A1Isoindolinone compounds, and uses thereofHANGZHOU GLUBIO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0944US2022050917A1Re-identification risk assessment using a synthetic estimatorReplica Analytics·Filed 2021·Application pending·0 cites
- 1040US2023083012A1Dihydropyrimidine derivatives and uses thereof in the treatment of hbv infection or of hbv-induced diseasesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2020·Application pending·0 cites
- 1136US2019119200A1Tertiary amides and method of useABBVIE INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Linglong Kong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →